Literature DB >> 7544695

[Expression of intercellular adhesion molecule-1 and vascular adhesion molecule-1 in kidney of patients with lupus nephritis and membranoproliferative glomerulonephritis].

X Chen1, Q Xu, L Tang.   

Abstract

Immunohistochemical and computer-imaging analysis techniques were used to detect the expression of intercellular adhesion molecule 1 (ICAM-1) and vascular adhesion molecule 1 (VCAM-1) in the kidney of 25 patients with lupus nephritis (LN) type IV and in 15 patients with membranoproliferative glomerulonephritis (MPGN) type I. Results showed that ICAM-1 and VCAM-1 expressions were increased significantly in the kidneys of patients with MPGN and LN and that ICAM-1 in the glomeruli of LN patients correlated well with glomerular endothelial cell proliferation. ICAM-1 and VCAM-1 may well take a role in the pathogenesis of LN and MPGN.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544695

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN: 0529-5807


  3 in total

1.  Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.

Authors:  Mohamed Ismail Abd-Elkareem; Hegazy Mogahed Al Tamimy; Osama A Khamis; Salama S Abdellatif; Mahmoud Rezk Abdelwahed Hussein
Journal:  Clin Exp Nephrol       Date:  2010-08-17       Impact factor: 2.801

2.  Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice.

Authors:  Kimihiko Nakatani; Shuhei Yoshimoto; Osamu Asai; Hirokazu Sakan; Miho Terada; Yoshihiko Saito; Masato Nose; Masayuki Iwano; Noboru Konishi
Journal:  Immun Inflamm Dis       Date:  2013-10-30

3.  ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.

Authors:  Ioannis Parodis; Sirisha Gokaraju; Agneta Zickert; Kamala Vanarsa; Ting Zhang; Deena Habazi; João Botto; Clara Serdoura Alves; Panagiotis Giannopoulos; Anders Larsson; Elisabet Svenungsson; Iva Gunnarsson; Chandra Mohan
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.